EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC-ND 4.0

Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors

Yoonhee Kim iD, Jeongjoo Park, Byunggak Kim, Kyung-Rok Yu, Hong Sook Kim, Yein Oh, Kyoungwon Seo, Minok Ryu, Chul Park, Dongha Bhang, Ulsoo Choi iD, Hwayoung Youn

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.16946 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Yoonhee Kim and 11 co-authors. Institution: College of Veterinary Medicine, Jeonbuk National University, 79 Gobong-ro, Iksan-si, Jeollabuk-do, South Korea. Major MEDLINE topics: Neoplasms, Dog Diseases. Cited 5 times so far (Crossref); 18 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Biattic Incorporated, Anyang, Korea.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

An accurate and easily accessible method for diagnosing malignancies in local veterinary clinics has not yet been established.

Objectives

To investigate the usefulness of serum thymidine kinase 1 (TK1) protein and its autoantibody as tumor biomarkers in dogs. Animals Serum samples from 1702 dogs were collected from local animal hospitals and referral animal medical centers in South Korea.

Methods

TK1 protein OD value and TK1 autoantibody ratio (TK1 autoantibody OD/total IgG OD) in serum samples of dogs classified into healthy controls, group with nontumor disease, group with benign and group with malignant tumors were measured using lateral flow immunochromatographic assay methods.

Results

TK1 autoantibody levels were significantly higher in malignant tumor group (median 0.71) than in healthy controls (median 0.34), group with nontumor disease (median 0.34), and group with benign tumor (median 0.32, Welch t test, P < .0001). They were also significantly different among dogs with carcinomas (median 0.77), hematopoietic tumors (median 0.71), and sarcomas (median 0.56) than in healthy controls (median 0.34, post hoc Games-Howell test, P < .0001). In the receiver operating characteristic curve of TK1 protein, AUC was 0.633 (95% CI: 0.592-0.675, P < .0001). The AUC of TK1 autoantibody ratio was 0.758 (95% CI: 0.723-0.793, P < .0001). Conclusions and Clinical Importance TK1 autoantibody is a potentially useful biomarker for differentiating between healthy and tumor-bearing dogs, better than TK1 protein measurement. However, both were inadequate when used as single biomarkers for screening dogs to discover occult malignant tumors.

Subjects

MeSH terms (MEDLINE)

NeoplasmsDog DiseasesDogsAnimalsAutoantibodiesBiomarkers, TumorThymidine Kinase

Author keywords

autoantibodybiomarkermalignant tumorsthymidine kinase 1 protein

Substances

thymidine kinase 1AutoantibodiesBiomarkers, TumorThymidine Kinase

Authors and institutions

  • College of Veterinary Medicine, Jeonbuk National University, 79 Gobong-ro, Iksan-si, Jeollabuk-do, South Korea.
  • Biattic Inc., #305, 16 Heungan-daero, Dongan-gu, Anyang-si, Gyeonggi-do, South Korea.
  • Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, South Korea.
  • Department of Biological Sciences, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, South Korea.
  • College of Veterinary Medicine, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu, South Korea.
  • College of Veterinary Medicine, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, South Korea.

ORCID profiles: Yoonhee Kim, Ulsoo Choi

Funding

  • Biattic Incorporated, Anyang, Korea

Cite

APA

Kim, Y., Park, J., Kim, B., Yu, K. R., Kim, H. S., Oh, Y., Seo, K., Ryu, M., Park, C., Bhang, D., Choi, U., & Youn, H. (2024). Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16946

Vancouver

Kim Y, Park J, Kim B, Yu KR, Kim HS, Oh Y, et al. Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.16946

BibTeX
@article{Kim2024,
  author = {Kim, Yoonhee and Park, Jeongjoo and Kim, Byunggak and Yu, Kyung-Rok and Kim, Hong Sook and Oh, Yein and Seo, Kyoungwon and Ryu, Minok and Park, Chul and Bhang, Dongha and Choi, Ulsoo and Youn, Hwayoung},
  title = {Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.16946}
}
Start for free →